SCHEMBL29068840

SCHEMBL29068840

Sc1ccccc1-c1ccncc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 1/20 0.47
▸ MAOB P27338 1/20 0.47
▸ IDO1 P14902 2/20 0.47
▸ LIMK1 P53667 12/20 0.45
▸ GSK3B P49841 2/20 0.45
▸ NFATC1 O95644 1/20 0.45
▸ DYRK1A Q13627 1/20 0.45
▸ CDC25B P30305 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ CDC7 O00311 1/20 0.39
▸ ROCK2 O75116 1/20 0.39
▸ MAP4K4 O95819 1/20 0.39
▸ PRKACA P17612 1/20 0.39
▸ CDK2 P24941 1/20 0.39
▸ HIPK2 Q9H2X6 1/20 0.39
▸ CLK4 Q9HAZ1 1/20 0.39
▸ MKNK2 Q9HBH9 1/20 0.39
▸ IRAK4 Q9NWZ3 1/20 0.39
▸ LIMK2 P53671 1/20 0.37
▸ GPBAR1 Q8TDU6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29191166 0.98 IDO1 (0.46) MAOAMAOBIDO1LIMK1GSK3B
SCHEMBL31301252 0.81 GSK3B (0.59) MAOAMAOBIDO1LIMK1GSK3B
SCHEMBL16456555 0.77 GPBAR1 (0.49) MAOAMAOBIDO1LIMK1GSK3B
SCHEMBL3954650 0.77 GSK3B (0.45) MAOAMAOBIDO1LIMK1GSK3B
SCHEMBL18174896 0.77 MAOA (0.47) MAOAMAOBIDO1LIMK1GPBAR1
SCHEMBL942740 0.77 CYP2A6 (0.50) MAOBIDO1
SCHEMBL29145045 0.74 CYP2A6 (0.48) MAOBIDO1
SCHEMBL3306203 0.74 CYP2A6 (0.54) MAOAMAOBIDO1GSK3BNFATC1
SCHEMBL20004071 0.73 SLC22A12 (0.51) GSK3BGAAGPBAR1
SCHEMBL30679641 0.73 IDO1 (0.43) MAOAMAOBIDO1LIMK1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116568308-A Heterocyclic SHP2 inhibitor, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2023-08-08 — — CN disclosed
Send feedback